An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Coleman Gross, MD
Corcept Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham School of Medicine
Birmingham, Alabama, United States
- Amcr Institute Inc.
Escondido, California, United States
- Stanford University Medical Center
Stanford, California, United States
- the Center for Diabetes and Endocrine Care
Hollywood, Florida, United States
- Northwestern University Feinberg Medical; Division of Endocrinology, Metabolism & Molecular Medicine
Chicago, Illinois, United States
- Sinai Hospital of Baltimore
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- University of New Mexico
Albuquerque, New Mexico, United States
- Cleveland Clinic Foundation; Dept of Endocrinology, Diabetes & Metabolism
Cleveland, Ohio, United States
- Oklahoma Diabetes Center
Oklahoma City, Oklahoma, United States
- Oregon Health Sciences University
Portland, Oregon, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Endocrinology Center at Community Medical Commons
Menomonee Falls, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2009
- Primary completion
- 30 Sept 2012
- Completion
- 30 Sept 2012
- Last update posted
- 2 Apr 2014
- Registered enrollment
- 30
- Registry id
- NCT00936741
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.